Results 171 to 180 of about 86,092 (288)

Rab3gap1 palmitoylation cycling modulates cardiomyocyte exocytosis and atrial natriuretic peptide release. [PDF]

Biophys J
Essandoh K, Eramo GA, Subramani A, Brody MJ.   +3 more
europepmc   +1 more source

Left Bundle Branch Area Pacing versus Deep Septal Pacing in Patients After Transcatheter Aortic Valve Replacement

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Left bundle branch area pacing (LBBAP) has been reported to improve long‐term clinical outcomes in patients requiring permanent pacemaker implantation (PPMI) after transcatheter aortic valve replacement (TAVR). Deep septal pacing (DSP) has emerged as a potential alternative to LBBAP.
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Relationship Between Human Atrial Natriuretic Peptide and Tricuspid Valve Annular Dilatation in Patients With Atrial Fibrillation. [PDF]

Echocardiography
Izumi K, Utsunomiya H, Tohgi K, Takeuchi M, Hamada A, Hyodo Y, Tsuchiya A, Mogami A, Ueda Y, Takahari K, Nakano Y.   +10 more
europepmc   +1 more source

Effect of adrenaline on serum mid-regional pro-atrial natriuretic peptide and central blood volume. [PDF]

Exp Physiol, 2022
Sejersen C, Bjerre-Bastos JJ, Goetze JP, Nielsen HB, Bihlet AR, Secher NH.   +5 more
europepmc   +1 more source

Prediction of incident heart failure in type 2 diabetes mellitus: Rationale and design of the DM‐HEART study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Preclinical heart failure (HF) (stages A and B) is common but easily overlooked in asymptomatic patients with type 2 diabetes (T2D). There is a paucity of evidence regarding how coexisting risk factors contribute to the development of HF in asymptomatic Asian patients with T2D, and there is a lack of guidance on the early identification of ...
Jiun‐Lu Lin, Yen‐Wen Wu, Sung‐Chen Liu, Chung‐Ming Tu, Heng‐Hsu Lin, Yi‐Fu Lin, Hao‐Yun Chang, Ming‐Nan Chien, Chih‐Yuan Wang, Chung‐Lieh Hung   +9 more
wiley   +1 more source

Bradykinin type 2 receptor deficiency alters vascular endothelial growth factor and atrial natriuretic peptide levels in early-stage diabetic retinopathy. [PDF]

J Cereb Blood Flow Metab
Radmilović M, Justić H, Barić A, Ratko M, Šimunić I, Vatavuk Z, Dugandžić A, Dobrivojević Radmilović M.   +7 more
europepmc   +1 more source

Role of atrial natriuretic peptide in the dissociation between flow relations with ventricular mass and function in a community with volume-dependent hypertension. [PDF]

Front Cardiovasc Med, 2023
Yusuf SM, Norton GR, Peterson VR, Mthembu N, Libhaber CD, Tade G, Bello H, Bamaiyi AJ, Mmopi KN, Dessein PH, Peters F, Sareli P, Woodiwiss AJ.   +12 more
europepmc   +1 more source

Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study

Journal of Diabetes Investigation, EarlyView.
SGLT2 inhibitor use at discharge was associated with a reduced risk of heart failure readmission in elderly patients with diabetes, with no significant differences among individual agents. ABSTRACT Aims To evaluate the effect of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration at hospital discharge on heart failure (HF) readmission ...
Kazuya Hiura, Hirotaka Masuda, Masayuki Sakunami, Miki Yamashita   +3 more
wiley   +1 more source

Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats. [PDF]

Eur Heart J Open
Bakhos JJ, Saliba Y, Hajal J, Achkouty G, Oskaridjian H, Albuquerque M, Azevedo C, Semaan A, Suffee N, Balse E, Hatem SN, Fares N.   +11 more
europepmc   +1 more source

The Correlations of Human Atrial Natriuretic Peptide on Cardiac Function and Hemodynamics in Pediatric Septic Shock. [PDF]

Open Access Emerg Med, 2022
Setyaningtyas A, Soetjipto S, Endaryanto A, Pudjiadi AH.   +3 more
europepmc   +1 more source